Lappaconitine Hydrobromide CAS 97792-45-5
Chemical Name: LAPPACONITINE HYDROBROMIDE
Synonyms: Lappaconite HBR; ALLAPININE HYDROBROMIDE
CAS No.: 97792-45-5
Molecular Fomula: C32H45BrN2O8
Molecular weight:?665.61
Appearance: Powder crystal
Assay: ??99.0%
发送询盘
Description
LAPPACONITINE HYDROBROMIDE Quick Details
Chemical Name: LAPPACONITINE HYDROBROMIDE
CAS No.: 97792-45-5
Molecular Fomula: C32H45BrN2O8
Chemical Structure:
Molecular weight:?665.61
Appearance: Powder crystal
Assay: ??99.0%
Typical Properties
ITEMS
SPECIFICATION
Storage
2-8??C
Melting point
223-226 oC
Solubility
Soluble in DMSO (little), methanol (little)
Color
White to light yellow to pale orange
Purity
99%
?
LAPPACONITINE HYDROBROMIDE?application:
For cancer pain, surgical pain, toothache, menstrual pain and other moderate or above pain.
Packaging and Shipping?
customized?according?to?customer?needs.
LAPPACONITINE HYDROBROMIDE?Storage
It should be?kept it away from light and seal it away.
5 |
|
0 |
4 |
|
0 |
3 |
|
0 |
2 |
|
0 |
1 |
|
0 |
- 2
- 2-diallylpent-4-en-1-amine
- 4
- 95-16-9
- Ammonium sulfamate
- Benzothiazole
- cas:67889-00-3ح2
- cas:83524-75-8 | pigment black 32
- cas:928836-00-4 | 2
- cas:932745-70-5 | 4
- Chemical Minerals
- Coconut diethanolamide
- Daily Chemicals
- discount
- for sale
- General pvc resin
- hexyl D-glucoside
- in stock
- Lauramidopropyl betaine
- LAURIC ACID MONOETHANOLAMIDE
- Petroleum Additives
- Plasticiser
- Ploymers
- price
- PVC
- quotation
- Raw Materal
- Remove term: Petroleum Additives Petroleum Additive
- SODIUM ETHYL 2-SULFOLAURATE
Related Products
Urapidil is a sympathetic antihypertensive drug. It acts as ?? 1 ?C adrenoceptor antagonists and 5-HT 1A receptor agonists act. Although the initial report showed that urapidil was also a ?? 2 ?C adrenoceptor agonist, which was not confirmed in later studies, proved that it had no agonist effect in the saphenous vein of dogs and ileum of guinea pigs. With others ?? Unlike 1-adrenoceptor villains, urapidil does not cause response tachycardia, which may be connected to its weak ?? 1-adrenoceptor antagonist activity and its impact on heart vagal drive. Urapidil has actually not been approved by the US Food and drug administration, yet it is offered in Europe.
Urapidil (URA), chemical name is 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl -2,4(1H,3H)-pyrimidinedione, trade name: ebrantil (ebrantil), synonym: excellent matchi, uracil substituted by phenazine.
Chemical Name: 1,1,2,2-Tetrachloroethane
Other Name: Tetrachlorethane
CAS No.: 79-34-5
Molecular Formula: C2H2Cl4
Molecular Weight: 167.85
Appearance: Liquid
Chemical Name:?Favipiravir
CAS No.:?259793-96-9
Molecular Fomula:?C5H4FN3O2
Molecular weight:?157.1
Appearance:?Off white solid
Assay: 99 % min
Chemical Name: Semaglutide
CAS No.: 910463-68-2
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.57754
Appearance: Powder
Levodopa, also known as L-DOPA or 3,4-dihydroxy-L-phenylalanine, is a naturally occurring amino acid and a critical precursor in the biosynthesis of the neurotransmitters dopamine, norepinephrine, and epinephrine. With the molecular formula C9H11NO4, levodopa is a large, neutral amino acid that plays a significant role in the treatment of Parkinson’s disease due to its ability to cross the blood-brain barrier and be converted into dopamine.
Chemically, levodopa is synthesized from the precursor amino acid tyrosine through the action of the enzyme tyrosine hydroxylase. As a medication, levodopa is often formulated with a peripheral DOPA decarboxylase inhibitor to reduce its conversion to dopamine outside the brain, thereby increasing its effectiveness and reducing side effects.
Levodopa is characterized by its effectiveness in alleviating the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia. It is typically administered orally and absorbed from the gastrointestinal tract, where it is then transported to the brain.
In summary, levodopa is a vital pharmaceutical compound used in neurology for its role in treating Parkinson’s disease by replenishing the brain’s dopamine levels. Its targeted delivery and conversion to dopamine make it an essential treatment option for managing the motor symptoms associated with this condition.
Chemical Name: 3-Hydroxybutyric acid
CAS No.: 625-71-8
Molecular Formula: C4H8O3
Molecular Weight: 104.1
Appearance: White powder
Chemical Name: Imazalil Sulfate
CAS No.: 58594-72-2
Molecular Formula: C14H14Cl2N2O.H2SO4
Molecular Weight: 395.26
Appearance: Solid
Chemical Name: Ammonium Iron(II) Sulfate
Synonyms: Diammonium iron bis(sulphate); iron (ii) ammonium sulfate
CAS No.: 10045-89-3
Molecular Formula: FeH5NO4S
Molecular Weight: 170.95
Chemical Name:Sodium Stibogluconate
CAS No.:16037-91-5
Appearance:?White liquid
Assay??99.0%
Chemical Name: STODDARD SOLVENT
CAS No.: 64742-88-7
Appearance: Colorless or Light Yellow Liquid
Levodopa, also known as L-DOPA or 3,4-dihydroxy-L-phenylalanine, is a naturally occurring amino acid and a critical precursor in the biosynthesis of the neurotransmitters dopamine, norepinephrine, and epinephrine. With the molecular formula C9H11NO4, levodopa is a large, neutral amino acid that plays a significant role in the treatment of Parkinson’s disease due to its ability to cross the blood-brain barrier and be converted into dopamine.
Chemically, levodopa is synthesized from the precursor amino acid tyrosine through the action of the enzyme tyrosine hydroxylase. As a medication, levodopa is often formulated with a peripheral DOPA decarboxylase inhibitor to reduce its conversion to dopamine outside the brain, thereby increasing its effectiveness and reducing side effects.
Levodopa is characterized by its effectiveness in alleviating the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia. It is typically administered orally and absorbed from the gastrointestinal tract, where it is then transported to the brain.
In summary, levodopa is a vital pharmaceutical compound used in neurology for its role in treating Parkinson’s disease by replenishing the brain’s dopamine levels. Its targeted delivery and conversion to dopamine make it an essential treatment option for managing the motor symptoms associated with this condition.
Common English name: 5-iodo-2,3-dihydropyridazin-3-one
CAS No.: 825633-94-1
Molecular formula: C4H3IN2O
Molecular weight: 221.98
Sample: Available
Reviews
There are no reviews yet.